Concerns about the lack of balanced information provided about left atrial appendage (LAA) closure procedures on the web pages of top US hospitals have been raised by a new study. The researchers ...
Please provide your email address to receive an email when new articles are posted on . OPTION is a head-to-head trial of left atrial appendage closure with Watchman FLX vs. anticoagulation after ...
SAN FRANCISCO -- Surprisingly, a course of direct oral anticoagulation (DOAC) may be the safer choice for antithrombotic treatment after left atrial appendage (LAA) occlusion, according to the ANDES ...
CHICAGO -- For patients at high risk of stroke who underwent catheter-based atrial fibrillation ablation, left atrial appendage closure led to less bleeding compared with oral anticoagulation, the ...
The current bias of medicine is strong. When we are in doubt, when evidence is sparse, doctors do more, not less. Internists prescribe, cardiologists implant, surgeons cut. We know what we know. So it ...
The global left atrial appendage closure (LAAC) devices market is projected to register a robust growth from 2025 to 2033.
Patients with atrial fibrillation (AF) and a history of breakthrough stroke—an ischemic stroke that occurs despite use of oral anticoagulation—have a heightened risk for subsequent cerebrovascular ...
Medical Device Network on MSN
Gore acquires Conformal Medical to broaden endovascular portfolio
Under the acquisition, Gore will inherit Conformal’s CLAAS AcuForm system for left atrial appendage closure to mitigate stroke risk.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results